Skip to content
PulseMS
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studySystematic reviewPeer review unconfirmed

Human Microbiome Alterations in Multiple Sclerosis

A systematic review found significant changes in the human microbiome of individuals with multiple sclerosis (MS), linking these alterations to disease phenotype, inflammation, and treatment methods. Notably, these microbiota changes affect immune responses, particularly in T cell differentiation along the Th17/IL-17 pathway.

Most relevant to
Neurologist, Immunologist
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

Understanding these microbiome alterations may reveal interactions between gut bacteria and immune responses in MS, contributing to insights into disease mechanisms.

What this does not prove

However, substantial methodological variability, the predominance of cross-sectional designs that limit causal insights, treatment confounders, and poor reproducibility of specific microbial findings reduce the strength of these associations.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Systematic review
Participants / samples
Not reported
Randomised
Not reported
Controlled
Not reported
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
2026-09-26
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified

Original sources

Supporting passages (5)
study designThis review critically synthesizes available evidence from studies demonstrating significant alterations in the composition of the human microbiome in individuals with MS.
subjectsThis review critically synthesizes available evidence from studies demonstrating significant alterations in the composition of the human microbiome in individuals with MS.
findingsOverall, the available evidence points to multilevel interactions between the microbiome, host genetics, metabolism, and the immune system in MS.
limitationsHowever, substantial methodological heterogeneity, predominantly cross-sectional study designs, treatment-related confounding, and limited reproducibility of taxon-specific findings currently restrict causal interpretation.
publication datePublication date: 2026-09-26

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.